LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Gadoterate Meglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent ...
First In-Man Experience Exceeds Expectations, Cited as “Game Changer” for Below-the-Knee Procedures CAMBRIDGE, Mass.--(BUSINESS WIRE)--Summa Therapeutics, LLC announced today that the first-in-man ...
The dose of contrast material can be effectively reduced by at least 10% for elderly patients undergoing a multi-detector CT examination of the pancreas and biliary region a new study finds. When the ...
"Reducing gadolinium exposure is not only a clinical priority but increasingly an environmental one," said Dr. Kate Hanneman, Radiologist & Deputy Lead for Sustainability at the Joint Department of ...
Designed for contrast media injections, the PowrSyringe is capable of an injection that is between 20 and 100% faster than a standard control syringe. Nothing beats the need for speed when it comes to ...
VUEWAY injection is highly stable and shows the highest relaxivity among gadolinium-based contrast agents available for clinical use i VUEWAY injection is approved for use in adult and pediatric ...
PARIS, France—Using a virtual coronary road-map overlay during angiography for complex PCI can significantly reduce the amount of iodinated contrast and the number of cineangiography runs, potentially ...
Northwest Hospital now has a new tool to help staff and patients fight against breast cancer. In May, the Randallstown-based facility implemented contrast enhanced mammography. This new service ...
Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results